🇺🇸 FDA
Pipeline program

LEUPRORELIN ACETATE, LEUPRORELIN ACETATE, ANASTROZOLE, GOSERELIN, LETROZOLE, GOSERELIN, EXEMESTANE, RIBOCICLIB

CLEE011O12001

Phase 3 small_molecule active

Quick answer

LEUPRORELIN ACETATE, LEUPRORELIN ACETATE, ANASTROZOLE, GOSERELIN, LETROZOLE, GOSERELIN, EXEMESTANE, RIBOCICLIB for HR-positive HER-2- negative Breast Cancer is a Phase 3 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).

Program details

Company
Novartis Ophthalmics Europe
Indication
HR-positive HER-2- negative Breast Cancer
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials